Author:
Cheetham Philippa,Petrylak Daniel P.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference53 articles.
1. . Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.;Petrylak;N Engl J Med,2004
2. . Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.;Tannock;N Engl J Med,2004
3. Taxol induces Bcl-2 phosphorylation and death of prostate cancer cells.;Haldar;Cancer Res,1996
4. Inactivation of Bcl-2 by phosphorylation.;Haldar;Proc Natl Acad Sci U S A,1995
5. Bcl2 is the guardian of microtubule integrity.;Haldar;Cancer Res,1997
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献